Show phenotypes

-
tree  Medical Subject Headings (MeSH) Human Phenotype Ontology (HPO)
Medical Subject Headings

Only the MeSH headings used in the annotation of phenotypes are displayed.
The numbers refer to the number of study phenotype methods annotated to that heading (at zero threshold) and all child headings where they exist.
The "OR" search operator is used when multiple headings are checked.







2020 MeSHlink created by U.S. National Library of Medicine


No data sets (in No Phenotypes) added to Browser
3,327 Phenotypes match your selection (showing 51-100)
Pages: 1 2 3 4 5 6 7 8 9 10 >>
Phenotype tested in Study Phenotype ontology annotation Total p-values in Study StudyAdd data sets to Browser Related Study data
Adolescent idiopathic scoliosis (HGVPM4042)
  • Scoliosis
3 GWAS of Adolescent idiopathic scoliosis (HGVST1993)
Adolescent idiopathic scoliosis (HGVPM4805)
  • Scoliosis
8 GWAS of Adolescent idiopathic scoliosis (HGVST2460)
Adolescent idiopathic scoliosis (HGVPM5898)
  • Scoliosis
1 GWAS of Adolescent idiopathic scoliosis (HGVST2990)
Adolescent idiopathic scoliosis (HGVPM6276)
  • Scoliosis
4 GWAS of Adolescent idiopathic scoliosis (HGVST3211)
Adolescent idiopathic scoliosis (HGVPM6879)
  • Scoliosis
1,317 GWAS of Adolescent idiopathic scoliosis (HGVST3487)
Adolescent idiopathic scoliosis (HGVPM7456)
  • Scoliosis
10 GWAS of Adolescent idiopathic scoliosis (HGVST3726)
Adolescent idiopathic scoliosis (HGVPM7658)
  • Scoliosis
31 GWAS of Adolescent idiopathic scoliosis (HGVST3822)
Adolescent idiopathic scoliosis (severe) (HGVPM3542)
  • Scoliosis
1 GWAS of Adolescent idiopathic scoliosis (severe) (HGVST1804)
Adult asthma (HGVPM4282)
  • Asthma
19 GWAS of Asthma (HGVST2139)
Adult asthma (HGVPM6781)
  • Asthma
2 GWAS of Asthma-chronic obstructive pulmonary disease overlap syndrome (HGVST3453)
Adult asthma (HGVPM7334)
  • Asthma
3 GWAS of Adult asthma (HGVST3670)
Adult asthma (HGVPM7537)
  • Asthma
5 GWAS of Adult asthma (HGVST3769)
Adult hearing aid use (HGVPM7817)
  • Hearing Loss
1 GWAS of Adult hearing difficulty (HGVST3882)
Adult hearing difficulty (HGVPM7818)
  • Hearing Loss
3 GWAS of Adult hearing difficulty (HGVST3882)
Advanced age-related macular degeneration (HGVPM4274)
  • Macular Degeneration
2 GWAS of Age-related macular degeneration (HGVST2132)
Advanced age-related macular degeneration (HGVPM4904)
  • Macular Degeneration
52 GWAS of Advanced age-related macular degeneration (HGVST2484)
Adverse response to antithyroid drugs in Graves disease (HGVPM6630)
  • Antithyroid Agents
  • Graves Disease
2 GWAS of Adverse response to antithyroid drugs in Graves disease (HGVST3376)
Adverse response to aromatase inhibitors (HGVPM1168)
  • Aromatase Inhibitors
  • Breast Neoplasms
1 GWAS of adverse response to aromatase inhibitors (HGVST679)
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (Allelic model) (HGVPM3179)
  • Drug-Related Side Effects and Adverse Reactions
2 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (Dominant model) (HGVPM3189)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (Recessive model) (HGVPM3204)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) (Allelic model) (HGVPM3168)
  • Drug-Related Side Effects and Adverse Reactions
4 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) (Dominant model) (HGVPM3198)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) (Recessive model) (HGVPM3212)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs) (Dominant model) (HGVPM3209)
  • Drug-Related Side Effects and Adverse Reactions
4 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs) (Recessive model) (HGVPM3210)
  • Drug-Related Side Effects and Adverse Reactions
2 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs) (Allelic model) (HGVPM3196)
  • Drug-Related Side Effects and Adverse Reactions
4 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs) (Dominant model) (HGVPM3200)
  • Drug-Related Side Effects and Adverse Reactions
2 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs) (Recessive model) (HGVPM3174)
  • Drug-Related Side Effects and Adverse Reactions
6 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs) (Allelic model) (HGVPM3176)
  • Drug-Related Side Effects and Adverse Reactions
2 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs) (Dominant model) (HGVPM3201)
  • Drug-Related Side Effects and Adverse Reactions
3 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs) (Recessive model) (HGVPM3178)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors) (Allelic model) (HGVPM3175)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors) (Dominant) (HGVPM3170)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors) (Recessive model) (HGVPM3183)
  • Drug-Related Side Effects and Adverse Reactions
4 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin) (Allelic model) (HGVPM3211)
  • Drug-Related Side Effects and Adverse Reactions
2 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin) (Dominant model) (HGVPM3208)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin) (Allelic model) (HGVPM3186)
  • Drug-Related Side Effects and Adverse Reactions
3 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin) (Dominant model) (HGVPM3181)
  • Drug-Related Side Effects and Adverse Reactions
3 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin) (Recessive model) (HGVPM3188)
  • Drug-Related Side Effects and Adverse Reactions
3 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin) (Allelic model) (HGVPM3195)
  • Drug-Related Side Effects and Adverse Reactions
2 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin) (Dominant model) (HGVPM3169)
  • Drug-Related Side Effects and Adverse Reactions
5 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide) (Allelic model) (HGVPM3207)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide) (Dominant model) (HGVPM3180)
  • Drug-Related Side Effects and Adverse Reactions
2 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) (Allelic model) (HGVPM3187)
  • Drug-Related Side Effects and Adverse Reactions
3 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) (Dominant model) (HGVPM3192)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) (Recessive model) (HGVPM3190)
  • Drug-Related Side Effects and Adverse Reactions
3 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin) (Allelic model) (HGVPM3177)
  • Drug-Related Side Effects and Adverse Reactions
1 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin) (Recessive model) (HGVPM3206)
  • Drug-Related Side Effects and Adverse Reactions
2 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) (Allelic model) (HGVPM3171)
  • Drug-Related Side Effects and Adverse Reactions
3 GWAS of Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (HGVST1662)